MERCK PROSCAR ADS HAVE CONTRIBUTED TO INCREASED BPH DIAGNOSES
MERCK PROSCAR ADS HAVE CONTRIBUTED TO INCREASED BPH DIAGNOSES by physicians, Merck U.S. Human Health Business Manager Keith Yothers maintained at a June 6 session on direct-to-consumer advertising at the Drug Information Association annual meeting in Washington, D.C. Yothers suggested that one reason for the jump in diagnoses of benign prostatic hyperplasia has been an effort to educate both consumers and physicians "since an 8 X 11 DTC ad can't communicate all the information about the product that a consumer might use."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth